References
- Melrose EB. Maternal deaths at King Edward VIII Hospital, Durban. S Afr Med J 1984; 65: 161–5
- Van Coeverden de Groot HA. Maternal mortality in Cape Town, 1978–1983. S Afr Med J 1986; 69: 797–802
- Catanzarite V, Quirk JG, Aisenbrey G. How do perinatologists manage preeclampsia. Am J Perinatol 1991; 8: 7–10
- Hutton JD, James DK, Stirrat GM, Douglas KA, Redman C WG. Management of severe preeclampsia and eclampsia by UK consultants. Br J Obstet Gynaecol 1992; 99: 554–6
- Mabie WC, Gonzalez AR, Sibai BM, Amon E. A comparative trial of Labetolol and hydralazine in the acute management of severe hypertension complicating pregnancy. Obstet Gynecol 1987; 70: 328–33
- Vink GJ, Moodley J. The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy. S Afr Med J 1982; 62: 475–7
- Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension seen with an intravenously given hydralazine bolus. Surg Gynecol Obstet 1985; 161: 240–4
- Paterson-Brown S, Robson SC, Redfern N, Walkinshaw SA, De Swiet M. Hydralazine boluses for the treatment of severe hypertension in preeclampsia. Br J Obstet Gynaecol 1994; 101: 409–13
- Van Zwieten PA. Pharmacologic profile of urapidil. Am J Cardiol 1989; 64: 1D–6D
- Kolassa N, Beller KD, Sanders KH. Involvement of the brain 5-HT la receptors in the hypotensive response to urapidil. Am J Cardiol 1989; 64: 7D–10D
- Hirschl MM, Seidler D, Zeiner A, Wagner A, Heinz G, Sterz F, Lagger AN. Intravenous urapidil versus sublingual nifedipine in the treatment of hypertensive emergencies. Am J Emerg Med 1993; 11: 653–6
- Kirsten R, Nelson K, Molz K, Haerlin R, Steinijans V. Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: a crossover study comparing infusion with an infusion-capsule combination. Europ J Clin Pharmacol 1987; 32: 61–5
- Mollhoff T, Rosiers P, Van Aken H. Urapidil, sodium nitroprusside and nitroglycerin: effects on haemodynamics, venous admixture and arterial oxygenation after coronary artery bypass grafting. Drugs 1990; 40(suppl 4)73–6
- Van Aken H, Puchstein C, Sickling K, Krahling H, Konig W. Antihypertensive treatment with urapidil does not increase ICP in patients. Intensive Care Med 1986; 12: 106–10
- Wacker J, Lewicka S, Haack D, Bastert G. Hypertension in pregnancy. J Steroid Biochem Molec Biol 1993; 45: 65–8
- Wacker J, Müller J, Grisschke EM, Unkels R, Bastert G. Antihypertensive therapy of pregnancy-induced-hypertension (PIH) with urapidil. Zentralbl Gynakol 1994; 116: 271–3
- Pritchard JA, Pritchard SA. Standardized treatment of 154 consecutive cases of eclampsia. Am J Obstet Gynecol 1975; 123: 543–52
- Cotton DB, Gonek B, Dornman KR. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulphate. Am J Obstet Gynecol 1984; 148: 162–5
- Marx GF, Schwalbe SS, Cho E, Whitty JE. Automated blood pressure measurements in labouring women: are they reliable. Am J Obstet Gynecol 1993; 168: 796–8
- Strandgaard S, Olesen J, Skinhoj E, Lassen NA. Autoregulation of brain circulation in severe arterial hypertension. Br Med J 1973; 507–10
- Naden RP, Redman C WG. Antihypertensive drugs in pregnancy. Symposium on medical disorders in pregnancy. Clin Perinatol 1985; 12: 521–8